{"id":"https://openalex.org/W4416069941","doi":"https://doi.org/10.1016/j.nucmedbio.2025.109227","title":"Labeling of [225Ac]Ac-P17-087, a PSMA-Targeting Agent for Radioligand Therapy","display_name":"Labeling of [225Ac]Ac-P17-087, a PSMA-Targeting Agent for Radioligand Therapy","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4416069941","doi":"https://doi.org/10.1016/j.nucmedbio.2025.109227"},"language":"en","primary_location":{"id":"doi:10.1016/j.nucmedbio.2025.109227","doi":"https://doi.org/10.1016/j.nucmedbio.2025.109227","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nucmedbio.2025.109227","pdf_url":null,"source":{"id":"https://openalex.org/S24354371","display_name":"Nuclear Medicine and Biology","issn_l":"0969-8051","issn":["0969-8051","1872-9614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine and Biology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027454270","display_name":"Karl Pl\u00f6essl","orcid":"https://orcid.org/0000-0001-7896-5900","observed_orcids":["https://orcid.org/0000-0001-7896-5900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl Ploessl","raw_affiliation_strings":["Five Eleven Pharma Inc, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025961784","display_name":"David Alexoff","orcid":"https://orcid.org/0000-0002-0612-1239","observed_orcids":["https://orcid.org/0000-0002-0612-1239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Alexoff","raw_affiliation_strings":["Five Eleven Pharma Inc, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Five Eleven Pharma Inc, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103053143","display_name":"Hank F. Kung","orcid":"https://orcid.org/0000-0002-8811-4402","observed_orcids":["https://orcid.org/0000-0002-8811-4402"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hank Kung","raw_affiliation_strings":["University of Pennsylvania, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, United States","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103053143"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31416691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"150-151","issue":null,"first_page":"109227","last_page":"109227"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/actinium-225","display_name":"actinium-225","score":0.8539999723434448},{"id":"https://openalex.org/keywords/radioligand-therapy","display_name":"radioligand therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/radiolabeling","display_name":"radiolabeling","score":0.6840000152587891},{"id":"https://openalex.org/keywords/prostate-specific-membrane-antigen","display_name":"prostate-specific membrane antigen","score":0.9169999957084656},{"id":"https://openalex.org/keywords/alpha-emitting-radionuclide","display_name":"alpha-emitting radionuclide","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.7660999894142151},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6850000023841858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.66839998960495},{"id":"https://openalex.org/C2909005528","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand Assay","level":3,"score":0.3677000105381012},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2736999988555908},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24959999322891235},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.24629999697208405},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24459999799728394},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.22840000689029694},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.19329999387264252}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.nucmedbio.2025.109227","doi":"https://doi.org/10.1016/j.nucmedbio.2025.109227","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nucmedbio.2025.109227","pdf_url":null,"source":{"id":"https://openalex.org/S24354371","display_name":"Nuclear Medicine and Biology","issn_l":"0969-8051","issn":["0969-8051","1872-9614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nuclear Medicine and Biology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2966678141","https://openalex.org/W4281254259","https://openalex.org/W3143892586","https://openalex.org/W3162363681","https://openalex.org/W3198881089","https://openalex.org/W4389380524","https://openalex.org/W4281260261","https://openalex.org/W4415941181","https://openalex.org/W4407894916","https://openalex.org/W7161791142"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2025-11-10T00:00:00"}